Medical Condition News

RSS

UTHealth professor to receive NIH Director's Pioneer Award

Valentin Dragoi, Ph.D., an associate professor of neurobiology and anatomy at The University of Texas Health Science Center at Houston (UTHealth), is one of 17 researchers to win a 2010 National Institutes of Health Director's Pioneer Award. The award supports scientists who propose revolutionary, high-impact approaches to major challenges in biomedical and behavioral research.

2 Sep 2010

Indiana reports fewer preventable medical errors; Kansas struggles to meet oral health needs

The Indianapolis Star: "Indiana's hospitals and ambulatory surgery centers reported a decrease in preventable medical errors last year -- including a 33 percent drop in the number of bed sores. Overall, 306 facilities reported 94 preventable medical errors in 2009, according to a report released Monday by the Indiana State Department of Health. That's down from 105 errors reported each year in 2008 and 2007. The 22 pressure ulcers, also called bed sores, reported for 2009 were the fewest since the state's medical-error reporting system began four years ago" (Lee, 8/31).

2 Sep 2010

Researchers to explore spatial patterns of obesity and risk factors

South Dakota State University researchers are using the tools of spatial analysis to explore nationwide data for insights on what influences obesity."We can identify and map some of these regions or 'hotspots' of high and low obesity," said associate professor Michael Wimberly of SDSU's Geographic Information Science Center of Excellence. "Ultimately what we want to do is explain what some of the drivers are."

2 Sep 2010

National Health Information Resource Center honors Interstitial Cystitis Association for special publication

The Interstitial Cystitis Association, the only nonprofit health association dedicated solely to improving the lives of those affected by interstitial cystitis (IC), was recently honored with an award from the National Health Information Resource Center. The organization received honors for a special issue of its ICA Update – a quarterly magazine focused on current IC research, treatment, and lifestyle issues.

2 Sep 2010

Postterm birth increases cerebral palsy risk: Study

While preterm birth is a known risk factor for cerebral palsy, an examination of data for infants born at term or later finds that compared with delivery at 40 weeks, birth at 37 or 38 weeks or at 42 weeks or later was associated with an increased risk of cerebral palsy, according to a study in the September 1 issue of JAMA.

2 Sep 2010

New research clinic in Edinburgh to improve outcomes for multiple sclerosis sufferers

A research clinic for multiple sclerosis patients is being set up with a -10 million donation from the author J K Rowling.The Anne Rowling Regenerative Neurology Clinic at the University of Edinburgh will place patients at the heart of research to improve outcomes for multiple sclerosis sufferers.

2 Sep 2010

Non-kidney transplant patients likely to undergo kidney transplant prior to dialysis: Study

Kidney failure may accompany or complicate transplantation of the liver, heart, or lung. Because increasing numbers of individuals are receiving non-kidney transplants, researchers have wondered whether more of such patients are being listed for kidney transplants.

2 Sep 2010

ESC announces new Clinical Practice Guidelines on Atrial Fibrillation

The European Society of Cardiology (ESC) today announces the release of new Clinical Practice Guidelines covering Atrial Fibrillation. These are the first guidelines to be prepared solely by the ESC on this very important topic.

2 Sep 2010

High vitamin D level improves survival rate in heart failure patients: Study

Survival rates in heart failure patients with reduced levels of vitamin D are lower than in patients with normal levels. This is the finding of a major study carried out at University Medical Center, Groningen, Netherlands. Results also suggest that low levels of vitamin D are associated with activation of the Renin Angiotensin System (RAS - a pivotal regulatory system in heart failure) and an altered cytokine profile.

2 Sep 2010

Prometheus launches Crohn's Prognostic test

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.

2 Sep 2010

Healthy eating impacts long-term success in workplace

Eating healthy and living well is about more than your waistline. Most people think about the visible impacts that healthy eating have on our lives, yet fail to consider what poor dietary habits can do to our careers.

2 Sep 2010

High levels of OPG hormone associated with adverse outcome after myocardial infarction

Patients suffering with heart failure are more likely to die if they have high levels of a bone hormone called osteoprotegerin (OPG).

2 Sep 2010

Pharmacor 2010 findings predict COPD drug market rise to $13 billion in 2019

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, through 2019, an expanding aging population and increases in diagnosis and drug treatment will fuel steady 4.6 percent annual growth in the chronic obstructive pulmonary disease (COPD) drug market.

2 Sep 2010

Consuming variety of fruits, vegetables may decrease squamous cell lung cancer risk: Study

Adding a variety of vegetables to one's diet may help decrease the chance of getting lung cancer, and adding a variety of fruits and vegetables may decrease the risk of squamous cell lung cancer, especially among smokers.

2 Sep 2010

Sangart reports positive MP4OX Phase IIa study data in severely injured trauma patients with hemorrhagic shock

Sangart, Inc., today announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients.

2 Sep 2010

DASH eating plan reduces heart disease risk in African Americans: Study

A new study suggests yet another reason for Americans to abandon their current fatty diets in favor of one rich in fruits and vegetables and low in saturated fat. Choosing these healthier options appears to significantly reduce the long-term risk of heart disease in patients with mildly elevated blood pressure, particularly African Americans.

2 Sep 2010

USFDA grants Sun Pharma subsidiary approval for generic Strattera capsules ANDA

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules.

2 Sep 2010

FDA approves LUMIGAN eye drops for intraocular pressure reduction in open-angle glaucoma patients

Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved LUMIGAN (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

2 Sep 2010

Event Pulse report reveals impact of new therapies on MS drug market

The study titled Event Pulse Preview: Multiple Sclerosis shows that 84% of neurologists expect to prescribe Gilenia for some MS patients if approved, but prescribing will likely be limited to second- or third-line therapy until concerns about safety and monitoring requirements are resolved.

1 Sep 2010

Parkinson’s disease discoveries

Genes that affect the immune system and link it to Parkinson’s disease have been uncovered. This paves the way for new drug development in Parkinson’s disease – a serious, degenerative disease of the nerves that leads to tremors and muscle stiffness and eventually complete loss of movements. There is currently no cure for PD.

31 Aug 2010

Medical Condition News

UTHealth professor to receive NIH Director's Pioneer Award

Indiana reports fewer preventable medical errors; Kansas struggles to meet oral health needs

Researchers to explore spatial patterns of obesity and risk factors

National Health Information Resource Center honors Interstitial Cystitis Association for special publication

Postterm birth increases cerebral palsy risk: Study

New research clinic in Edinburgh to improve outcomes for multiple sclerosis sufferers

Non-kidney transplant patients likely to undergo kidney transplant prior to dialysis: Study

ESC announces new Clinical Practice Guidelines on Atrial Fibrillation

High vitamin D level improves survival rate in heart failure patients: Study

Prometheus launches Crohn's Prognostic test

Healthy eating impacts long-term success in workplace

High levels of OPG hormone associated with adverse outcome after myocardial infarction

Pharmacor 2010 findings predict COPD drug market rise to $13 billion in 2019

Consuming variety of fruits, vegetables may decrease squamous cell lung cancer risk: Study

Sangart reports positive MP4OX Phase IIa study data in severely injured trauma patients with hemorrhagic shock

DASH eating plan reduces heart disease risk in African Americans: Study

USFDA grants Sun Pharma subsidiary approval for generic Strattera capsules ANDA

FDA approves LUMIGAN eye drops for intraocular pressure reduction in open-angle glaucoma patients

Event Pulse report reveals impact of new therapies on MS drug market

Parkinson’s disease discoveries

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News